Cite
HARVARD Citation
Miller, K. et al. (2016). HERMIONE: a randomized Phase 2 trial of MM-302 plus trastuzumab versus chemotherapy of physician's choice plus trastuzumab in patients with previously treated, anthracycline-naïve, HER2-positive, locally advanced/metastatic breast cancer. BMC cancer. 16 (1), pp. 1-11. [Online].